Real‐world effectiveness, drug survival and safety of risankizumab over a period of 2 years in 158 patients with moderate‐to‐severe plaque psoriasis
Saved in:
| Published in | Journal of the European Academy of Dermatology and Venereology Vol. 39; no. 1; pp. e1 - e4 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
01.01.2025
|
| Online Access | Get full text |
| ISSN | 0926-9959 1468-3083 1468-3083 |
| DOI | 10.1111/jdv.19956 |
Cover
| Author | Befon, Angeliki Papoutsaki, Marina Rigopoulos, Dimitrios Rompoti, Natalia Koumprentziotis, Ioannis‐Alexios Nicolaidou, Electra Vavouli, Charitomeni Politou, Maria Zaimi, Maria Panagakis, Pantelis Kousta, Fiori Lazou, Eleni Stefanaki, Irene Chasapi, Vasiliki Stratigos, Alexander |
|---|---|
| Author_xml | – sequence: 1 givenname: Natalia orcidid: 0000-0002-9326-6726 surname: Rompoti fullname: Rompoti, Natalia email: natalia.rompoti@gmail.com organization: National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 2 givenname: Irene orcidid: 0000-0002-2964-370X surname: Stefanaki fullname: Stefanaki, Irene organization: National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 3 givenname: Pantelis surname: Panagakis fullname: Panagakis, Pantelis organization: National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 4 givenname: Marina surname: Papoutsaki fullname: Papoutsaki, Marina organization: National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 5 givenname: Maria surname: Politou fullname: Politou, Maria organization: National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 6 givenname: Charitomeni surname: Vavouli fullname: Vavouli, Charitomeni organization: National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 7 givenname: Angeliki surname: Befon fullname: Befon, Angeliki organization: National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 8 givenname: Fiori surname: Kousta fullname: Kousta, Fiori organization: National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 9 givenname: Eleni surname: Lazou fullname: Lazou, Eleni organization: National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 10 givenname: Maria surname: Zaimi fullname: Zaimi, Maria organization: National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 11 givenname: Ioannis‐Alexios surname: Koumprentziotis fullname: Koumprentziotis, Ioannis‐Alexios organization: National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 12 givenname: Vasiliki surname: Chasapi fullname: Chasapi, Vasiliki organization: National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 13 givenname: Dimitrios orcidid: 0000-0002-4841-7484 surname: Rigopoulos fullname: Rigopoulos, Dimitrios organization: National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 14 givenname: Alexander surname: Stratigos fullname: Stratigos, Alexander organization: National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 15 givenname: Electra orcidid: 0000-0002-8221-0217 surname: Nicolaidou fullname: Nicolaidou, Electra organization: National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38506605$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kc1u1DAUhS1URKeFBS-AvASpae1k7MRLVCg_qoSEgK11E1-DSxIH28loWHXLjgfg6fokuMx0g8ALX-n6O-faPkfkYPQjEvKYs1Oe19mVWU65UkLeIyu-lk1RsaY6ICumSlnkvjokRzFeMcY4F80Dclg1gknJxIr8eo_Q31z_3PjQG4rWYpfcgiPGeEJNmD_TOIfFLdBTGA2NYDFtqbc0uAjjV_d9HqClfsFAgU4YnDe3p-XN9Y8tQojUjTTPpBMkh2OKdOPSFzp4gwES5sHJ5y1iNkA69fBtziX64CC6-JDct9BHfLSvx-TjxcsP56-Ly3ev3pw_vyy6qhSyqAUTypatkko1ClsQvDHrupXIu06KljOEuoQ1462QtZVtZRppVcWq1nLgpjomT3e-U_D5AjHpwcUO-x5G9HPUparLmlW8YRl9skfndkCjp-AGCFt996MZONsBXfAxBrS6cyk_3o8pgOs1Z_o2M50z038yy4pnfynuTP_F7t03rsft_0H99sWnneI3chSsAA |
| CitedBy_id | crossref_primary_10_1007_s00403_024_03419_w |
| Cites_doi | 10.3390/jcm12041675 10.1007/s13555‐022‐00795‐x 10.1111/dth.15524 10.1016/S0140‐6736(19)30952‐3 10.1080/09546634.2022.2081655 10.1001/jamadermatol.2020.3617 10.1016/S0140‐6736(18)31713‐6 10.1111/jdv.16521 10.1111/bjd.19341 10.3390/jcm12093233 |
| ContentType | Journal Article |
| Copyright | 2024 European Academy of Dermatology and Venereology. |
| Copyright_xml | – notice: 2024 European Academy of Dermatology and Venereology. |
| DBID | AAYXX CITATION NPM 7X8 |
| DOI | 10.1111/jdv.19956 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1468-3083 |
| EndPage | e4 |
| ExternalDocumentID | 38506605 10_1111_jdv_19956 JDV19956 |
| Genre | correspondence Letter Correspondence |
| GroupedDBID | --- --K .3N .GA .Y3 05W 0R~ 10A 1B1 1OB 1OC 1~5 29L 31~ 33P 36B 3SF 4.4 4G. 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 7-5 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEDT AAESR AAEVG AAHHS AAHQN AAIPD AALRI AAMNL AANHP AANLZ AAONW AAQFI AAQXK AASGY AAXRX AAXUO AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABQWH ABWVN ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADMUD ADNMO ADOZA ADZMN AE3 AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFTJW AFWVQ AFZJQ AHBTC AHEFC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG CO8 COF CS3 CYRXZ D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD ESX EX3 F00 F01 F04 F5P FDB FEDTE FGOYB FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M41 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 NF~ NQ- O66 O9- OIG OVD OZT P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K R2- RIG RIWAO RJQFR ROL RPZ RX1 SAMSI SEW SUPJJ TEORI UB1 UHS W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT AAYXX ACVFH ADCNI AEUPX AEYWJ AFPUW AGHNM AGQPQ AGYGG AIGII CITATION NPM 7X8 AAMMB AEFGJ AGXDD AIDQK AIDYY |
| ID | FETCH-LOGICAL-c3256-75059f2b969989eba518d47b6e1cc65b10ea72a401b567f6b3d86f9303bf1a1d3 |
| IEDL.DBID | DR2 |
| ISSN | 0926-9959 1468-3083 |
| IngestDate | Fri Jul 11 00:30:11 EDT 2025 Wed Feb 19 01:58:46 EST 2025 Thu Apr 24 23:05:27 EDT 2025 Tue Jul 01 05:03:22 EDT 2025 Wed Jan 22 17:11:50 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3256-75059f2b969989eba518d47b6e1cc65b10ea72a401b567f6b3d86f9303bf1a1d3 |
| Notes | content type line 23 SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 |
| ORCID | 0000-0002-8221-0217 0000-0002-9326-6726 0000-0002-2964-370X 0000-0002-4841-7484 |
| PMID | 38506605 |
| PQID | 2972703180 |
| PQPubID | 23479 |
| PageCount | 4 |
| ParticipantIDs | proquest_miscellaneous_2972703180 pubmed_primary_38506605 crossref_citationtrail_10_1111_jdv_19956 crossref_primary_10_1111_jdv_19956 wiley_primary_10_1111_jdv_19956_JDV19956 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | January 2025 2025-01-00 2025-Jan 20250101 |
| PublicationDateYYYYMMDD | 2025-01-01 |
| PublicationDate_xml | – month: 01 year: 2025 text: January 2025 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Journal of the European Academy of Dermatology and Venereology |
| PublicationTitleAlternate | J Eur Acad Dermatol Venereol |
| PublicationYear | 2025 |
| References | 2022; 12 2022; 35 2021; 184 2020; 156 2020; 34 2018; 392 2023; 12 2022; 33 2019; 394 e_1_2_3_2_1 e_1_2_3_6_1 e_1_2_3_5_1 e_1_2_3_4_1 e_1_2_3_3_1 e_1_2_3_9_1 e_1_2_3_8_1 e_1_2_3_7_1 e_1_2_3_10_1 e_1_2_3_11_1 |
| References_xml | – volume: 12 issue: 4 year: 2023 article-title: Risankizumab therapy for moderate‐to‐severe psoriasis‐a multi‐center, long‐term, real‐life study from Poland publication-title: J Clin Med – volume: 392 start-page: 650 issue: 10148 year: 2018 end-page: 661 article-title: Efficacy and safety of risankizumab in moderate‐to‐severe plaque psoriasis (UltIMMa‐1 and UltIMMa‐2): results from two double‐blind, randomised, placebo‐controlled and ustekinumab‐controlled phase 3 trials publication-title: Lancet – volume: 12 start-page: 2309 issue: 10 year: 2022 end-page: 2324 article-title: Real‐life effectiveness and safety of Risankizumab in 131 patients affected by moderate‐to‐severe plaque psoriasis: a 52‐week retrospective study publication-title: Dermatol Ther (Heidelb) – volume: 35 issue: 7 year: 2022 article-title: Risankizumab treatment in psoriasis patients who failed anti‐IL17: a 52‐week real‐life study publication-title: Dermatol Ther – volume: 34 start-page: 2830 issue: 12 year: 2020 end-page: 2838 article-title: Efficacy of risankizumab in patients with moderate‐to‐severe plaque psoriasis by baseline demographics, disease characteristics and prior biologic therapy: an integrated analysis of the phase III UltIMMa‐1 and UltIMMa‐2 studies publication-title: J Eur Acad Dermatol Venereol – volume: 33 start-page: 2813 issue: 6 year: 2022 end-page: 2820 article-title: Real‐world practice indirect comparison between guselkumab, risankizumab, and tildrakizumab: results from an Italian 28‐week retrospective study publication-title: J Dermatolog Treat – volume: 394 start-page: 576 issue: 10198 year: 2019 end-page: 586 article-title: Risankizumab compared with adalimumab in patients with moderate‐to‐severe plaque psoriasis (IMMvent): a randomised, double‐blind, active‐comparator‐controlled phase 3 trial publication-title: Lancet – volume: 156 start-page: 1344 issue: 12 year: 2020 end-page: 1353 article-title: Effect of Risankizumab on patient‐reported outcomes in moderate to severe psoriasis: the UltIMMa‐1 and UltIMMa‐2 randomized clinical trials publication-title: JAMA Dermatol – volume: 184 start-page: 50 issue: 1 year: 2021 end-page: 59 article-title: Efficacy and safety of risankizumab vs. secukinumab in patients with moderate‐to‐severe plaque psoriasis (IMMerge): results from a phase III, randomized, open‐label, efficacy‐assessor‐blinded clinical trial publication-title: Br J Dermatol – volume: 12 issue: 9 year: 2023 article-title: Long‐term efficacy and safety of Risankizumab for moderate to severe psoriasis: a 2‐year real‐life retrospective study publication-title: J Clin Med – ident: e_1_2_3_8_1 doi: 10.3390/jcm12041675 – ident: e_1_2_3_9_1 doi: 10.1007/s13555‐022‐00795‐x – ident: e_1_2_3_11_1 doi: 10.1111/dth.15524 – ident: e_1_2_3_6_1 doi: 10.1016/S0140‐6736(19)30952‐3 – ident: e_1_2_3_10_1 doi: 10.1080/09546634.2022.2081655 – ident: e_1_2_3_2_1 doi: 10.1001/jamadermatol.2020.3617 – ident: e_1_2_3_4_1 doi: 10.1016/S0140‐6736(18)31713‐6 – ident: e_1_2_3_3_1 doi: 10.1111/jdv.16521 – ident: e_1_2_3_5_1 doi: 10.1111/bjd.19341 – ident: e_1_2_3_7_1 doi: 10.3390/jcm12093233 |
| SSID | ssj0001158 |
| Score | 2.437894 |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e1 |
| Title | Real‐world effectiveness, drug survival and safety of risankizumab over a period of 2 years in 158 patients with moderate‐to‐severe plaque psoriasis |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjdv.19956 https://www.ncbi.nlm.nih.gov/pubmed/38506605 https://www.proquest.com/docview/2972703180 |
| Volume | 39 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 0926-9959 databaseCode: DR2 dateStart: 19970101 customDbUrl: isFulltext: true eissn: 1468-3083 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001158 providerName: Wiley-Blackwell |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqHhAX3o_lpQFx4ECqdRx71-KEgKqqBIeKoh6QIju20aolWa2TSu2pV278AH5dfwkzTrJQHhLiEkWK4zj2PL6xx58Ze2rU3BVVKDLhuc-KueGZtVxkxlWB7J_kLmX5vlM7-8XugTzYYC_GvTA9P8R6wo00I9lrUnBj489K7o5pq50kum0uZFqi3ftBHYVIJ1lhnauMOLUGVqGUxTO-edEX_QYwL-LV5HC2r7KPY1P7PJPDra61W9XpLyyO__kv19iVAYjCy15yrrMNX99gl94OS-032bc9hJDnZ18TpSr0aR-DZXwObtV9gtihmUFBBVM7iCb49gSaAMTaWx8uTrvPxgIliIIBolNuHD3Nz8--nKB2RVjUgJ0HA7FrBJoRBjqYh8gr8MNtgxf0237lYXlksNNgGRvUl7iIt9j-9pv3r3ay4SiHrBIIqjLEJVKH3GqF4Z321kiOMjKzyvOqUtLyqTez3GCwZ6WaBWWFm6ug0b_awA134jbbrJva32UwLYp8KuZ5MMRVx7XRQnpRBK_9zKAfnrBn46CW1cBzTsdtHJXreMcdl6m3J-zJuuiyJ_f4U6HHo2SUqHq0nmJq33SxzDWCPzKK0wm704vMuhpBTIAYKmJr0sD_vf5y9_WHdHPv34veZ5dzOoc4TQU9YJvtqvMPERy19lHSgu-V5xAp |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkYALb-jyHBAHDqRax4l3LXFBlGopbQ9Vi3pBkR3baNU2WW2SSu2pV278AH5dfwkzTrJQHhLiEkWK4zj2PL6xx58Ze6Hl2Ca5TyLhuIuSseaRMVxE2uae7F_Kbcjy3ZaTvWRjP91fYq_7vTAtP8Riwo00I9hrUnCakP5Zy-0x7bVL5SV2mdbnSC3Xdn6QRyHWCXZYxTIiVq2OVyjk8fSvXvRGv0HMi4g1uJz1G-xT39g20-RgtanNan76C4_j__7NTXa9w6LwphWeW2zJFbfZla1utf0O-7aDKPL87GtgVYU286Mzjq_AzpvPUDVoaVBWQRcWKu1dfQKlByLuLQ6mp82RNkA5oqCBGJVLS0_j87MvJ6hgFUwLwN6Djtu1ApoUBjqbh_gr8MN1iRd03W7uYHaosddgVpWoMtW0usv21t_tvp1E3WkOUS4QV0UITVLlY6MkRnjKGZ1yFJORkY7nuUwNHzo9ijXGeyaVIy-NsGPpFbpY47nmVtxjy0VZuBUGwySJh2Ice010dVxpJVInEu-UG2l0xQP2sh_VLO-ozunEjcNsEfLY4yz09oA9XxSdtfwefyr0rBeNDLWPllR04cqmymKF-I_s4nDA7rcys6hGEBkgRovYmjDyf68_21j7GG4e_HvRp-zqZHdrM9t8v_3hIbsW07HEYWboEVuu5417jFipNk-CSnwHdpEURQ |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkSou5U0XCgyIAwdSrePEu1ZPiLIqBSpUUdQDUmTHNlq1JKtNUqk99cqNH8Cv6y9hxkkWykNCXKJIcRzHnsc39vgzY0-0HNsk90kkHHdRMtY8MoaLSNvck_1LuQ1Zvrtyez_ZOUgPlthmvxem5YdYTLiRZgR7TQo-s_5nJbfHtNUulZfY5URidEWIaO8HdxRCnWCGVSwjItXqaIVCGk__6kVn9BvCvAhYg8eZXGUf-7a2iSaHG01tNvLTX2gc__NnrrHVDonC81Z0rrMlV9xgK2-7tfab7NseYsjzs6-BUxXavI_OND4DO28-QdWgnUFJBV1YqLR39QmUHoi2tzicnjaftQHKEAUNxKdcWnoan599OUH1qmBaAHYedMyuFdCUMNDJPMRegR-uS7yg43ZzB7MjjZ0Gs6pEhamm1S22P3n5_sV21J3lEOUCUVWEwCRVPjZKYnynnNEpRyEZGel4nsvU8KHTo1hjtGdSOfLSCDuWXqGDNZ5rbsVttlyUhVtjMEySeCjGsddEVseVViJ1IvFOuZFGRzxgT_tBzfKO6JzO2zjKFgGPPc5Cbw_Y40XRWcvu8adCj3rJyFD3aEFFF65sqixWiP7IKg4H7E4rMotqBFEBYqyIrQkD__f6s52tD-Hm7r8XfchW3m1Nsjevdl_fY1diOpM4TAuts-V63rj7CJRq8yAoxHc9TRL0 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Real-world+effectiveness%2C+drug+survival+and+safety+of+risankizumab+over+a+period+of+2%E2%80%89years+in+158+patients+with+moderate-to-severe+plaque+psoriasis&rft.jtitle=Journal+of+the+European+Academy+of+Dermatology+and+Venereology&rft.au=Rompoti%2C+Natalia&rft.au=Stefanaki%2C+Irene&rft.au=Panagakis%2C+Pantelis&rft.au=Papoutsaki%2C+Marina&rft.date=2025-01-01&rft.eissn=1468-3083&rft.volume=39&rft.issue=1&rft.spage=e1&rft_id=info:doi/10.1111%2Fjdv.19956&rft_id=info%3Apmid%2F38506605&rft.externalDocID=38506605 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0926-9959&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0926-9959&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0926-9959&client=summon |